Drug Type Small molecule drug |
Synonyms HS 10376, HS-10376, HS10376 |
Target |
Action inhibitors |
Mechanism EGFR exon 20 inhibitors(EGFR exon 20 Mutation inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | China | 30 Sep 2021 | |
EGFR ex20ins mutation in non-small cell lung cancer | Phase 1 | China | 11 Oct 2021 |